✦ LIBER ✦

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

✍ Scribed by Kazuaki Chayama; Shoichi Takahashi; Joji Toyota; Yoshiyasu Karino; Kenji Ikeda; Hiroki Ishikawa; Hideaki Watanabe; Fiona McPhee; Eric Hughes; Hiromitsu Kumada

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 905 KB
Volume: 55
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24724

No coin nor oath required. For personal study only.

✦ Synopsis

The following corrections have since been made: ''BMS-790052'' has been replaced throughout with ''daclatasvir''; ''BMS-50032'' has been replaced throughout with ''asunaprevir''. The article has been updated online and in print.

📜 SIMILAR VOLUMES

Multiple ascending dose study of BMS-790

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

✍ Richard E. Nettles; Min Gao; Marc Bifano; Ellen Chung; Anna Persson; Thomas C. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Abbreviations: AE, adverse event; AUC, area under the plasma concentration time curve; AUC (TAU) , AUC over 12-hour dosing interval for 30 mg twice daily; C min , minimum observed plasma concentration; C max , maximum observed plasma concentration; C trough , trough concentrations; CLT/F, apparent t

Mutations in the nonstructural protein 5

Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection

✍ Komatsu, Haruki; Fujisawa, Tomoo; Inui, Ayano; Miyagawa, Yoshihiro; Onoue, Masah 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 3 views

A region associated with sensitivity to interferon (IFN) has been identified previously in the nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) genotype 1b. A study was undertaken to determine whether the presence of mutations in the NS5A 2209-2248 sequence could serve as a predictor of re

HCV796: A selective nonstructural protei

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

✍ Norman M. Kneteman; Anita Y. M. Howe; Tiejun Gao; Jamie Lewis; Dan Pevear; Gary 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Anti -hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clinical study. This manuscript outlines activity and correlation across such a spectrum of models and into clinical trials with a novel selective